West Park Healthcare Centre, Toronto, Ontario, Canada.
J Cardiopulm Rehabil Prev. 2009 Sep-Oct;29(5):318-24. doi: 10.1097/HCR.0b013e3181ac7bb8.
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) impair health-related quality of life (HRQL). We evaluated the effect of an abbreviated repeat pulmonary rehabilitation (PR) program on HRQL after an AECOPD.
Patients who had completed PR were followed for up to 12 months to identify an AECOPD and then placed in randomized groups to receive a 3-week repeat-PR intervention or usual care. Measures of HRQL (Chronic Respiratory Disease Questionnaire, CRQ) and functional exercise capacity (6-minute walk distance, 6MWD) were collected at 2 (T(1)), 5 (T(2)), and 12 weeks (T(3)) post-AECOPD. The repeat-PR program was undertaken between T(1) and T(2). Between-group differences were examined using repeated- measures analysis of variance or covariance.
Of the 60 patients (30 men, age 69+/-8 years, forced expiratory volume in 1 second 0.86+/-0.40 L, 6MWD 367+/-99 m) followed, 41 experienced an AECOPD 14 +/- 11 weeks after completion of the initial PR program and 33 completed the study. Of these, 16 and 17 were randomized to the intervention and control groups, respectively. No between-group differences were demonstrated at T(2) or T(3). With the exclusion of 5 subjects who experienced a second AECOPD between T(1) and T(3), the participants in the intervention group demonstrated greater reduction in dyspnea when compared to those in the control group at T(3) (0.8+/-1.6 vs -0.4+/-1.3 points per item, P = .04).
The reduction in dyspnea in those who did not experience a second AECOPD provides preliminary evidence for the role of repeat programs. The application of repeat PR should be refined in larger trials.
慢性阻塞性肺疾病(COPD)急性加重(AECOPD)会损害健康相关生活质量(HRQL)。我们评估了 AECOPD 后,简短重复肺康复(PR)方案对 HRQL 的影响。
对已完成 PR 的患者进行了长达 12 个月的随访,以确定 AECOPD,并将其随机分为重复 PR 干预组或常规护理组。在 AECOPD 后 2(T1)、5(T2)和 12 周(T3)时,收集 HRQL(慢性呼吸系统疾病问卷,CRQ)和功能运动能力(6 分钟步行距离,6MWD)的测量值。重复 PR 方案在 T1 和 T2 之间进行。使用重复测量方差或协方差分析来检查组间差异。
在 60 名患者(30 名男性,年龄 69+/-8 岁,第 1 秒用力呼气量 0.86+/-0.40 L,6MWD 367+/-99 m)中,41 名患者在初始 PR 方案完成后 14 +/- 11 周发生 AECOPD,33 名患者完成了研究。其中,16 名和 17 名患者分别被随机分配到干预组和对照组。在 T2 或 T3 时,两组间没有差异。在排除 T1 和 T3 之间发生第二次 AECOPD 的 5 名患者后,与对照组相比,干预组患者的呼吸困难在 T3 时的改善更为明显(0.8+/-1.6 与-0.4+/-1.3 分/项,P=0.04)。
未发生第二次 AECOPD 的患者呼吸困难的减轻提供了重复方案作用的初步证据。应在更大规模的试验中进一步完善重复 PR 的应用。